HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glutaric aciduria type 1 (glutaryl-CoA-dehydrogenase deficiency): advances and unanswered questions. Report from an international meeting.

Abstract
Infants with macrocephaly, young children with acute disease resembling encephalitis, and children with truncal hypotonia, ataxia, or dystonia may be affected by glutaric aciduria type I (GA 1, glutaryl-CoA-dehydrogenase deficiency), a not-so-rare autosomal recessive neurometabolic disease. Well-known features of GA1 are fronto-temporal brain atrophy with macrocephaly and acute encephalopathic episodes with striatal necrosis followed by dystonia, but some patients develop motor disease without overt crises and other biochemically affected individuals remain asymptomatic. Biochemical and molecular characterization is available and allows post- and prenatal diagnosis. The pathogenesis of fronto-temporal atrophy, macrocephaly, and basal ganglia necrosis is still not understood, and there is no close correlation between biochemical parameters and clinical outcome. There is, however, evidence suggesting that carnitine supplementation and anticatabolic treatment of intercurrent illness may arrest or prevent neurological deterioration, while the role of limitation of dietary lysine and tryptophane is not yet clear. Although pathogenetic aspects are poorly understood, the natural course of glutaric aciduria type 1 can be changed by early diagnosis and treatment. Coordinated research is needed to understand the pathogenesis of brain toxicity, to define the role of dietary therapy, and to explore the possibility of neonatal screening.
AuthorsA Superti-Furga, G F Hoffmann
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 156 Issue 11 Pg. 821-8 (Nov 1997) ISSN: 0340-6199 [Print] Germany
PMID9392391 (Publication Type: Congress, Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Oxidoreductases
  • Oxidoreductases Acting on CH-CH Group Donors
  • Glutaryl-CoA Dehydrogenase
Topics
  • Brain Diseases (enzymology)
  • Child
  • Child, Preschool
  • Developmental Disabilities (enzymology)
  • Female
  • Glutaryl-CoA Dehydrogenase
  • Humans
  • Infant
  • Metabolism, Inborn Errors (diagnosis, enzymology, epidemiology, physiopathology, therapy)
  • Oxidoreductases (deficiency)
  • Oxidoreductases Acting on CH-CH Group Donors
  • Pregnancy
  • Prenatal Diagnosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: